|
|
|
Insider
Information: |
Perry Mark L |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
275,485 |
|
Indirect Shares
|
123,600 |
|
|
Direct
Value |
$26,169,364 |
|
|
Indirect Value
|
$111,723,636 |
|
|
Total
Shares |
399,085 |
|
|
Total
Value |
$137,893,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
Percentage
Gain/Loss : |
0.0%
|
215.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
EVP Operations |
2004-02-03 |
196,040 |
2004-02-03 |
5,600 |
Premium* |
|
Nuvelo Inc |
ABIO |
Director |
2006-09-28 |
65,833 |
2006-09-28 |
0 |
Premium* |
|
NVIDIA Corporation |
NVDA |
Director |
2024-04-02 |
13,612 |
2024-04-02 |
118,000 |
Premium* |
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2022-10-05 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ABIO |
Nuvelo Inc |
Director |
|
2006-09-28 |
4 |
OE |
$6.50 |
$596,989 |
D/D |
65,833 |
65,833 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2008-01-18 |
4 |
OE |
$8.47 |
$423,500 |
D/D |
50,000 |
50,000 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2011-04-06 |
4 |
S |
$17.41 |
$3,046,330 |
D/D |
(175,000) |
50,000 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2011-04-06 |
4 |
OE |
$8.47 |
$1,482,250 |
D/D |
175,000 |
225,000 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2012-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
16,281 |
66,281 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
17,307 |
17,307 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,208 |
45,796 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2015-02-18 |
4 |
OE |
$9.67 |
$464,160 |
D/D |
48,000 |
93,796 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2015-02-18 |
4 |
S |
$22.20 |
$1,065,499 |
D/D |
(48,000) |
45,796 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
10,283 |
56,079 |
0 |
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2015-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,428 |
|
- |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2015-08-17 |
4 |
B |
$20.00 |
$100,000 |
D/D |
5,000 |
26,428 |
2.39 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2015-11-12 |
4 |
S |
$30.49 |
$1,219,704 |
D/D |
(40,000) |
56,079 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2015-11-12 |
4 |
OE |
$12.46 |
$498,400 |
D/D |
40,000 |
96,079 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2016-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
6,213 |
62,292 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2016-07-13 |
4 |
S |
$52.93 |
$1,852,463 |
D/D |
(35,000) |
62,292 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2016-07-13 |
4 |
OE |
$17.78 |
$622,300 |
D/D |
35,000 |
97,292 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2017-03-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
40,000 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2017-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,058 |
64,350 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2017-08-14 |
4 |
S |
$162.24 |
$2,641,369 |
D/D |
(16,281) |
48,069 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2018-02-12 |
4 |
S |
$227.93 |
$3,944,805 |
D/D |
(17,307) |
30,762 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2018-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
963 |
31,725 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2019-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,258 |
32,983 |
0 |
- |
|
NVDA |
NVIDIA Corporation |
Director |
|
2020-02-18 |
4 |
S |
$288.71 |
$2,556,747 |
D/D |
(8,752) |
24,231 |
0 |
% |
|
GBT |
Global Blood Therapeutics... |
Director |
|
2020-05-12 |
4 |
OE |
$18.85 |
$1,181,500 |
D/D |
53,600 |
80,028 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|